Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

The Special Liver Reset Recipe, although not standardized in scientific literature, is a term commonly used to describe a ...

The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Echinacea is a well-known immune booster often used to prevent and treat respiratory infections. Its ability to enhance the immune response can help the body fight off pathogens contributing to ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.

The drug, also known as inebilizumab, has now become the first FDA-approved treatment for Immunoglobulin G4-related disease ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

Asthma diagnosis QOF guidance has been updated for 2025/26 so that it no longer conflicts with NICE’s separate UK joint ...